A Long View of Life Science Growth

During his 22-year career, Adam Sichol has had a front-row seat on the life science industry’s expansion into Greater Boston’s most dynamic commercial real estate sector and played a hand in companies’ growth and relocations.

10 CRE Stories to Watch in 2019

As projects in Somerville, East Boston, Allston-Brighton and South End move forward, developers of large vacant commercial properties in Newton and Woburn are laying out plans for mixed-use projects totaling over 3 million square feet.

Making The Grade

The Massachusetts Biotechnology Council (MassBio) is a private nonprofit committed to expanding the life science and health care industries in the Bay State. Its members include biomedical firms, academic hospitals and allied organizations.

Life Science Is Part Of Alexandria’s DNA

Alexandria Real Estate Equities owns more than 6 million square feet of life science properties in Greater Boston, or approximately one-third of its national portfolio, but it still has room to grow. The Pasadena, California REIT acquired the Metropolitan Pipe & Supply Co. property in Cambridge’s Kendall Square this spring for $80.25 million and is drawing up plans for the life science mecca’s latest major lab complex. Alexandria also is testing the suburban market’s demand for additional life science space, as it converts two floors of office space to labs at 266-275 Second Ave. in Waltham after acquiring the property in July for $70.7 million. Tom Andrews leads the company’s Greater Boston operations including development of the 2.6-million-square-foot Alexandria Center at Kendall Square campus.

Cambridge Sets The Bar For Life Science Market

Cambridge, one of the top three life sciences markets nationally, is considered the epicenter due to numerous factors. The most significant is proximity and access to area universities and research institutions, such as MIT, Harvard, the Broad Institute and the Whitehead Institute.